Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium
Objective
To determine whether microRNAs (miRNAs) are differentially expressed in human leiomyoma versus matched myometrial tissue.
Design
Microarray with real-time polymerase chain reaction (PCR) validation.
Setting
Academic medical center.
Patient(s)
Premenopausal subjects (n = 15), who were undergoing hysterectomies for leiomyoma-related symptoms.
Intervention(s)
None.
Main Outcome Measure(s)
Statistically differential expression of miRNAs in leiomyoma versus myometrium.
Result(s)
Forty-six miRNA species were differentially expressed in leiomyoma versus normal myometrium. Of these, 19 were overexpressed and 27 were underexpressed in leiomyomas. The changes ranged from 1.2-fold to 11.8-fold. These findings were confirmed using real-time reverse transcriptase PCR for selected miRNAs (miRNAs 21, 34a, 125b, 139, and 323).
Conclusion(s)
Our findings indicate that miRNAs are differentially expressed between human leiomyoma and matched myometrium. Given this differential expression, miRNAs may play a role in the pathogenesis of uterine leiomyoma and may serve as future therapeutic targets for the treatment of these tumors.
Key Words: miRNA, microarray, uterine leiomyoma, myometrium
To access this article, please choose from the options below
Supported by NIH Grant HD46260 and the Friends of Prentice of Northwestern Memorial Hospital; Dr. Marsh received support from an Eleanor Wood-Prince Grant of the Women's Board of Northwestern Memorial Hospital, the Young Investigators Award from the Northwestern Memorial Foundation, and the ACOG/Ortho Women's Health Fellowship in Academic Medicine.
PII: S0015-0282(07)01220-4
doi:10.1016/j.fertnstert.2007.05.074
© 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

